These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1097 related items for PubMed ID: 33422448

  • 1. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M, Jung EE, Bresee C, Garcia MM.
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [Abstract] [Full Text] [Related]

  • 2. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study.
    Zaliznyak M, Lauzon M, Stelmar J, Yuan N, Smith SM, Garcia MM.
    Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753
    [Abstract] [Full Text] [Related]

  • 3. Variability in Medicaid Coverage for Gender-affirming Surgeries Across U.S. States.
    Wu CA, Ho I, Minasian A, Keuroghlian AS, O'Brien-Coon D, Ranganathan K.
    Ann Surg; 2024 Mar 01; 279(3):542-548. PubMed ID: 37395609
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L, Zhang Q, Getahun D, Jasuja GK, McCracken C, Pisegna J, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M.
    J Sex Med; 2021 Sep 01; 18(9):1662-1675. PubMed ID: 34366264
    [Abstract] [Full Text] [Related]

  • 5. Insurance Coverage of Facial Gender Affirmation Surgery: A Review of Medicaid and Commercial Insurance.
    Gorbea E, Gidumal S, Kozato A, Pang JH, Safer JD, Rosenberg J.
    Otolaryngol Head Neck Surg; 2021 Dec 01; 165(6):791-797. PubMed ID: 33722109
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
    Schneider F, Wistuba J, Holterhus PM, Kulle A, Schlatt S, Kliesch S, Neuhaus N, Zitzmann M.
    J Sex Med; 2021 Oct 01; 18(10):1807-1817. PubMed ID: 34600646
    [Abstract] [Full Text] [Related]

  • 8. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T, Mattawanon N, Manojai N, Muangmool T, Tangpricha V.
    J Sex Med; 2022 May 01; 19(5):864-871. PubMed ID: 35379590
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gender Affirming Medical Treatment Desire and Treatment Motives in Binary and Non-Binary Transgender Individuals.
    Kennis M, Duecker F, T'Sjoen G, Sack AT, Dewitte M.
    J Sex Med; 2022 Jul 01; 19(7):1173-1184. PubMed ID: 35418328
    [Abstract] [Full Text] [Related]

  • 12. The Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy Is Associated With High Patient Satisfaction.
    Spanos C, Grace JA, Leemaqz SY, Brownhill A, Cundill P, Locke P, Wong P, Zajac JD, Cheung AS.
    J Sex Med; 2021 Jan 01; 18(1):201-208. PubMed ID: 33249011
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
    Liu Y, Xin Y, Qi J, Wang H, Hong T, Yang X, Li B, Chang X, Knudson G, Zhao Z, Pan B.
    J Sex Med; 2020 Nov 01; 17(11):2291-2298. PubMed ID: 32868262
    [Abstract] [Full Text] [Related]

  • 15. How Early in Life do Transgender Adults Begin to Experience Gender Dysphoria? Why This Matters for Patients, Providers, and for Our Healthcare System.
    Zaliznyak M, Yuan N, Bresee C, Freedman A, Garcia MM.
    Sex Med; 2021 Dec 01; 9(6):100448. PubMed ID: 34731778
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C, Castellini G, Iacuaniello D, Romani A, Maggi M, Vignozzi L, Schreiner T, den Heijer M, T'Sjoen G, Fisher AD.
    J Sex Med; 2021 Apr 01; 18(4):821-829. PubMed ID: 33745831
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endocrine, gender dysphoria, and sexual function benefits of gender-affirming bilateral orchiectomy: patient outcomes and surgical technique.
    Stelmar J, Victor R, Yuan N, Smith SM, Mallavarapu S, Sandhu S, Garcia MM.
    Sex Med; 2024 Aug 01; 12(4):qfae048. PubMed ID: 39211910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.